| BAFNA PHARMACEUTICALS  | 
BAFNA PHARMACEUTICALS Last 5 Year Balance Sheet History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | 
| Equity - Authorised | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr | 
| Equity - Issued | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | 
| Equity Paid Up | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | 
| Equity Shares Forfeited | - | - | - | - | - | 
| Adjustments to Equity | - | - | - | - | - | 
| Preference Capital Paid Up | - | - | - | - | - | 
| Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | 
| Share Warrants & Outstandings | - | - | - | - | - | 
| Total Reserves | ₹61 Cr | ₹57 Cr | ₹50 Cr | ₹38 Cr | ₹33 Cr | 
| Securities Premium | ₹75 Cr | ₹75 Cr | ₹75 Cr | ₹75 Cr | ₹75 Cr | 
| Capital Reserves | ₹27 Cr | ₹27 Cr | ₹27 Cr | ₹27 Cr | ₹27 Cr | 
| Profit & Loss Account Balance | ₹-43 Cr | ₹-47 Cr | ₹-54 Cr | ₹-66 Cr | ₹-71 Cr | 
| General Reserves | ₹1.92 Cr | ₹1.92 Cr | ₹1.92 Cr | ₹1.92 Cr | ₹1.92 Cr | 
| Other Reserves | - | - | - | - | - | 
| Reserve excluding Revaluation Reserve | ₹61 Cr | ₹57 Cr | ₹50 Cr | ₹38 Cr | ₹33 Cr | 
| Revaluation reserve | - | - | - | - | - | 
| Shareholder's Funds | ₹85 Cr | ₹81 Cr | ₹73 Cr | ₹62 Cr | ₹57 Cr | 
| Minority Interest | - | - | - | - | - | 
| Long-Term Borrowings | - | - | - | - | - | 
| Secured Loans | ₹13 Cr | ₹9.25 Cr | ₹6.93 Cr | ₹3.30 Cr | ₹2.50 Cr | 
| Non Convertible Debentures | - | - | - | - | - | 
| Converible Debentures & Bonds | - | - | - | - | - | 
| Packing Credit - Bank | - | - | - | - | - | 
| Inter Corporate & Security Deposit | - | - | - | - | - | 
| Term Loans - Banks | ₹18 Cr | ₹13 Cr | ₹9.51 Cr | ₹4.45 Cr | - | 
| Term Loans - Institutions | - | - | - | - | ₹2.50 Cr | 
| Other Secured | ₹-5.60 Cr | ₹-3.63 Cr | ₹-2.58 Cr | ₹-1.15 Cr | - | 
| Unsecured Loans | ₹1.50 Cr | ₹1.50 Cr | ₹1.51 Cr | ₹2.02 Cr | - | 
| Fixed Deposits - Public | - | - | - | - | - | 
| Loans and advances from subsidiaries | - | - | - | - | - | 
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - | 
| Foreign Currency Convertible Notes | - | - | - | - | - | 
| Long Term Loan in Foreign Currency | - | - | - | - | - | 
| Loans - Banks | - | - | - | - | - | 
| Loans - Govt. | - | - | - | - | - | 
| Loans - Others | ₹1.50 Cr | ₹1.50 Cr | ₹1.51 Cr | ₹2.02 Cr | - | 
| Other Unsecured Loan | - | - | - | - | - | 
| Deferred Tax Assets / Liabilities | - | - | - | - | - | 
| Deferred Tax Assets | - | - | - | - | - | 
| Deferred Tax Liability | - | - | - | - | - | 
| Other Long Term Liabilities | ₹1.91 Cr | ₹1.62 Cr | ₹1.22 Cr | ₹0.85 Cr | ₹2.79 Cr | 
| Long Term Trade Payables | - | - | - | - | - | 
| Long Term Provisions | ₹0.48 Cr | ₹0.39 Cr | - | - | ₹0.10 Cr | 
| Total Non-Current Liabilities | ₹16 Cr | ₹13 Cr | ₹9.65 Cr | ₹6.17 Cr | ₹5.39 Cr | 
| Current Liabilities | - | - | - | - | - | 
| Trade Payables | ₹31 Cr | ₹35 Cr | ₹28 Cr | ₹12 Cr | ₹11 Cr | 
| Sundry Creditors | ₹31 Cr | ₹35 Cr | ₹28 Cr | ₹12 Cr | ₹11 Cr | 
| Acceptances | - | - | - | - | - | 
| Due to Subsidiaries- Trade Payables | - | - | - | - | - | 
| Other Current Liabilities | ₹11 Cr | ₹7.39 Cr | ₹4.85 Cr | ₹3.46 Cr | ₹3.62 Cr | 
| Bank Overdraft / Short term credit | - | - | - | - | - | 
| Advances received from customers | ₹0.84 Cr | ₹0.16 Cr | ₹0.04 Cr | - | ₹0.89 Cr | 
| Interest Accrued But Not Due | ₹0.08 Cr | ₹0.09 Cr | ₹0.11 Cr | - | - | 
| Share Application Money | - | - | - | - | - | 
| Current maturity of Debentures & Bonds | - | - | - | - | - | 
| Current maturity - Others | - | - | - | - | - | 
| Other Liabilities | ₹10 Cr | ₹7.13 Cr | ₹4.70 Cr | ₹3.46 Cr | ₹2.73 Cr | 
| Short Term Borrowings | ₹8.57 Cr | ₹10 Cr | ₹12 Cr | ₹4.59 Cr | ₹10.00 Cr | 
| Secured ST Loans repayable on Demands | ₹8.57 Cr | ₹10 Cr | ₹12 Cr | ₹4.59 Cr | - | 
| Working Capital Loans- Sec | ₹8.57 Cr | ₹10 Cr | ₹12 Cr | ₹4.59 Cr | - | 
| Buyers Credits - Unsec | - | - | - | - | - | 
| Commercial Borrowings- Unsec | - | - | - | - | - | 
| Other Unsecured Loans | ₹-8.57 Cr | ₹-10 Cr | ₹-12 Cr | ₹-4.59 Cr | ₹10.00 Cr | 
| Short Term Provisions | ₹1.38 Cr | ₹1.27 Cr | ₹1.26 Cr | ₹1.56 Cr | - | 
| Proposed Equity Dividend | - | - | - | - | - | 
| Provision for Corporate Dividend Tax | - | - | - | - | - | 
| Provision for Tax | - | - | - | - | - | 
| Provision for post retirement benefits | - | - | - | - | - | 
| Preference Dividend | - | - | - | - | - | 
| Other Provisions | ₹1.38 Cr | ₹1.27 Cr | ₹1.26 Cr | ₹1.56 Cr | - | 
| Total Current Liabilities | ₹52 Cr | ₹54 Cr | ₹46 Cr | ₹22 Cr | ₹24 Cr | 
| Total Liabilities | ₹153 Cr | ₹148 Cr | ₹130 Cr | ₹90 Cr | ₹86 Cr | 
| ASSETS | |||||
| Gross Block | ₹106 Cr | ₹99 Cr | ₹95 Cr | ₹88 Cr | ₹80 Cr | 
| Less: Accumulated Depreciation | ₹47 Cr | ₹59 Cr | ₹54 Cr | ₹49 Cr | ₹44 Cr | 
| Less: Impairment of Assets | - | - | - | - | - | 
| Net Block | ₹59 Cr | ₹40 Cr | ₹40 Cr | ₹39 Cr | ₹36 Cr | 
| Lease Adjustment A/c | - | - | - | - | - | 
| Capital Work in Progress | ₹7.31 Cr | ₹10 Cr | - | - | ₹0.83 Cr | 
| Non Current Investments | ₹0.00 Cr | - | - | - | - | 
| Long Term Investment | ₹0.00 Cr | - | - | - | - | 
| Quoted | - | - | - | - | - | 
| Unquoted | ₹0.00 Cr | - | - | - | - | 
| Long Term Loans & Advances | ₹0.81 Cr | ₹0.74 Cr | ₹0.54 Cr | ₹0.42 Cr | - | 
| Other Non Current Assets | - | ₹0.70 Cr | - | - | - | 
| Total Non-Current Assets | ₹67 Cr | ₹54 Cr | ₹42 Cr | ₹39 Cr | ₹37 Cr | 
| Current Assets Loans & Advances | - | - | - | - | - | 
| Currents Investments | - | - | - | - | - | 
| Quoted | - | - | - | - | - | 
| Unquoted | - | - | - | - | - | 
| Inventories | ₹28 Cr | ₹30 Cr | ₹22 Cr | ₹20 Cr | ₹15 Cr | 
| Raw Materials | ₹19 Cr | ₹15 Cr | ₹13 Cr | ₹9.77 Cr | ₹9.82 Cr | 
| Work-in Progress | ₹3.82 Cr | ₹9.13 Cr | ₹5.15 Cr | ₹1.19 Cr | ₹0.97 Cr | 
| Finished Goods | ₹1.93 Cr | ₹3.07 Cr | ₹2.20 Cr | ₹3.24 Cr | ₹1.68 Cr | 
| Packing Materials | - | - | - | - | ₹2.73 Cr | 
| Stores  and Spare | ₹3.11 Cr | ₹2.78 Cr | ₹1.96 Cr | ₹6.08 Cr | ₹0.24 Cr | 
| Other Inventory | - | - | - | - | - | 
| Sundry Debtors | ₹40 Cr | ₹45 Cr | ₹41 Cr | ₹15 Cr | ₹9.56 Cr | 
| Debtors more than Six months | ₹2.41 Cr | ₹3.52 Cr | ₹4.72 Cr | ₹2.08 Cr | - | 
| Debtors Others | ₹38 Cr | ₹43 Cr | ₹37 Cr | ₹13 Cr | ₹9.56 Cr | 
| Cash and Bank | ₹3.43 Cr | ₹1.40 Cr | ₹7.81 Cr | ₹0.17 Cr | ₹1.80 Cr | 
| Cash in hand | ₹0.01 Cr | ₹0.01 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | 
| Balances at Bank | ₹3.42 Cr | ₹1.39 Cr | ₹7.81 Cr | ₹0.17 Cr | ₹1.80 Cr | 
| Other cash and bank balances | - | - | - | - | - | 
| Other Current Assets | ₹0.62 Cr | ₹0.57 Cr | ₹0.37 Cr | ₹0.28 Cr | ₹12 Cr | 
| Interest accrued on Investments | - | - | ₹0.00 Cr | - | - | 
| Interest accrued on Debentures | - | - | - | - | - | 
| Deposits with Government | ₹0.10 Cr | ₹0.10 Cr | - | - | ₹0.35 Cr | 
| Interest accrued and or due on loans | - | ₹0.00 Cr | - | - | - | 
| Prepaid Expenses | ₹0.52 Cr | ₹0.46 Cr | ₹0.37 Cr | ₹0.28 Cr | ₹0.23 Cr | 
| Other current_assets | - | - | - | - | ₹11 Cr | 
| Short Term Loans and Advances | ₹12 Cr | ₹17 Cr | ₹16 Cr | ₹15 Cr | ₹11 Cr | 
| Advances recoverable in cash or in kind | ₹1.38 Cr | ₹0.84 Cr | ₹1.02 Cr | ₹0.64 Cr | ₹11 Cr | 
| Advance income tax and TDS | ₹0.30 Cr | ₹0.65 Cr | ₹0.48 Cr | ₹0.63 Cr | ₹0.56 Cr | 
| Amounts due from directors | - | - | - | - | - | 
| Due From Subsidiaries | - | - | - | - | - | 
| Inter corporate deposits | - | - | - | - | - | 
| Corporate Deposits | - | - | - | - | - | 
| Other Loans & Advances | ₹11 Cr | ₹15 Cr | ₹14 Cr | ₹14 Cr | ₹0.16 Cr | 
| Total Current Assets | ₹85 Cr | ₹94 Cr | ₹87 Cr | ₹51 Cr | ₹50 Cr | 
| Net Current Assets (Including Current Investments) | ₹33 Cr | ₹40 Cr | ₹41 Cr | ₹29 Cr | ₹25 Cr | 
| Miscellaneous Expenses not written off | - | - | - | - | - | 
| Total Assets | ₹153 Cr | ₹148 Cr | ₹130 Cr | ₹90 Cr | ₹86 Cr | 
| Contingent Liabilities | ₹18 Cr | ₹18 Cr | ₹10 Cr | ₹6.17 Cr | ₹2.00 Cr | 
| Total Debt | ₹28 Cr | ₹24 Cr | ₹23 Cr | ₹11 Cr | ₹13 Cr | 
| Book Value | - | 34.17 | 31.05 | 26.19 | 24.00 | 
| Adjusted Book Value | 35.85 | 34.17 | 31.05 | 26.19 | 24.00 | 
Compare Balance Sheet of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹366.0 Cr | -4% | 27.6% | 72.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | 0.2% | 7.1% | -7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,089.0 Cr | 1% | 16.8% | 12.7% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -2.7% | 3.5% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,456.0 Cr | 0.6% | 0.4% | 4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,965.9 Cr | -6.4% | -2.7% | -3.9% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| BAFNA PHARMACEUTICALS | -4% | 27.6% | 72.4% | 
| SENSEX | -0.3% | 4.5% | 5.7% | 
You may also like the below Video Courses
 
                     
                                     
                                     
                                    